Skip to main content
Erschienen in: Journal of Clinical Immunology 3/2017

21.02.2017 | Letter to Editor

Diagnosis of Interstitial Lung Disease Caused by Possible Hypersensitivity Pneumonitis in a Child: Think CGD

verfasst von: Saliha Esenboga, Nagehan Emiralioglu, Deniz Cagdas, Baran Erman, Martin De Boer, Berna Oguz, Nural Kiper, İlhan Tezcan

Erschienen in: Journal of Clinical Immunology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Interstitial lung disease (ILD) is a rare and heterogeneous group of disorder affecting the lung parenchyma and has a detrimental effect on gas exchange. Chronic granulomatous disease (CGD), when it affects primarily lungs, may cause ILD. We report a 16-year-old patient with CGD caused by homozygous deletion of NCF1 who atypically presented with ILD. The patient had many pigeons and was a pigeon breeder. Exacerbated clinical symptoms were linked to hypersensitivity pneumonitis (HP), and the patient was suggested to keep away from pigeons. In addition to allergen avoidance and prophylactic antibacterial therapy, treatment with corticosteroids and hydroxychloroquine was started for mainly obstructive and persistant symptoms of ILD. CGD is known to cause a hyperinflammatory state and the patients present with excessive granuloma formation and HP. Control of inflammation either by avoidance of allergen exposure and by anti-inflammatory drugs is necessary for the relief of symptoms.
Literatur
1.
Zurück zum Zitat Soares JJ, Deutsch GH, Moore PE, Fazili MF, Austin ED, Brown RF, Sokolow AG, Hilmes MA, Young LR. Childhood interstitial lung diseases: an 18-year retrospective analysis. Pediatrics. 2013;132(4):684–91.CrossRefPubMedPubMedCentral Soares JJ, Deutsch GH, Moore PE, Fazili MF, Austin ED, Brown RF, Sokolow AG, Hilmes MA, Young LR. Childhood interstitial lung diseases: an 18-year retrospective analysis. Pediatrics. 2013;132(4):684–91.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Buchvald F, Petersen BL, Damgaard K, Deterding R, Langston C, Fan LL, Deutsch GH, Dishop MK, Kristensen LA, Nielsen KG. Frequency, treatment, and functional outcome in children with hypersensitivity pneumonitis. PediatrPulmonol. 2011;46(11):1098–107. Buchvald F, Petersen BL, Damgaard K, Deterding R, Langston C, Fan LL, Deutsch GH, Dishop MK, Kristensen LA, Nielsen KG. Frequency, treatment, and functional outcome in children with hypersensitivity pneumonitis. PediatrPulmonol. 2011;46(11):1098–107.
3.
Zurück zum Zitat Mahdaviani SA, Mohejerani SA, Rezaei N, et al. Pulmonary manifestations of chronic granulomatous disease. Expert Rev Clin Immunol. 2013;9:153–60.CrossRefPubMed Mahdaviani SA, Mohejerani SA, Rezaei N, et al. Pulmonary manifestations of chronic granulomatous disease. Expert Rev Clin Immunol. 2013;9:153–60.CrossRefPubMed
4.
Zurück zum Zitat Leiding JW, Holland SM. Chronic granulomatous disease. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, StephensK, editors. GeneReviews1[Internet]. Seattle, WA: University of Washington;2012. pp. 1993–2014 Leiding JW, Holland SM. Chronic granulomatous disease. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, StephensK, editors. GeneReviews1[Internet]. Seattle, WA: University of Washington;2012. pp. 1993–2014
5.
Zurück zum Zitat Holland SM. Chronic granulomatous disease. Clin Rev AllergyImmunol. 2010;38(1):3–10.CrossRef Holland SM. Chronic granulomatous disease. Clin Rev AllergyImmunol. 2010;38(1):3–10.CrossRef
6.
Zurück zum Zitat van de Veerdonk FL, Smeekens SP, Joosten LA, Kullberg BJ, Dinarello CA, van der Meer JW, et al. Reactive oxygen species independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci U S A. 2010;107(7):3030–3.CrossRefPubMedPubMedCentral van de Veerdonk FL, Smeekens SP, Joosten LA, Kullberg BJ, Dinarello CA, van der Meer JW, et al. Reactive oxygen species independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci U S A. 2010;107(7):3030–3.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Turul ÖT, Türkkanı AG, Tezcan İ, Köker MY, Metin A, Yel L, Ersoy F, Sanal Ö. Clinical features of chronic granulomatous disease: a series of 26 patients from a single center. Turk J Pediatr. 2010;52:576–81. Turul ÖT, Türkkanı AG, Tezcan İ, Köker MY, Metin A, Yel L, Ersoy F, Sanal Ö. Clinical features of chronic granulomatous disease: a series of 26 patients from a single center. Turk J Pediatr. 2010;52:576–81.
8.
Zurück zum Zitat De Ravin SS, Naumann N, Cowen EW, Friend J, Hilligoss D, Marquesen M, et al. Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol. 2008;122(6):1097–103.CrossRefPubMedPubMedCentral De Ravin SS, Naumann N, Cowen EW, Friend J, Hilligoss D, Marquesen M, et al. Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol. 2008;122(6):1097–103.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Seger RA. Modern management of chronic granulomatous disease. Br J Haematol. 2008;140(3):255–66.CrossRefPubMed Seger RA. Modern management of chronic granulomatous disease. Br J Haematol. 2008;140(3):255–66.CrossRefPubMed
10.
Zurück zum Zitat Song E, Jaishankar GB, Saleh H, Jithpratuck W, Sahni R, Krishnaswamy G. Chronic granulomatous disease: a review of the infectious and inflammatory complications. ClinMol Allergy. 2011;9(1):10. Song E, Jaishankar GB, Saleh H, Jithpratuck W, Sahni R, Krishnaswamy G. Chronic granulomatous disease: a review of the infectious and inflammatory complications. ClinMol Allergy. 2011;9(1):10.
11.
Zurück zum Zitat Kawai T, Watanabe N, Yokoyama M, Nakazawa Y, Goto F, Uchiyama T, Higuchi M, Maekawa T, Tamura E, Nagasaka S, Hojo M, Onodera M. Interstitial lung disease with multiple microgranulomas in chronic granulomatous disease. J Clin Immunol. 2014;34(8):933–40.CrossRefPubMed Kawai T, Watanabe N, Yokoyama M, Nakazawa Y, Goto F, Uchiyama T, Higuchi M, Maekawa T, Tamura E, Nagasaka S, Hojo M, Onodera M. Interstitial lung disease with multiple microgranulomas in chronic granulomatous disease. J Clin Immunol. 2014;34(8):933–40.CrossRefPubMed
12.
Zurück zum Zitat Katsuya Y, Hojo M, Kawai S, Kawai T, Onodera M, Sugiyama H. Chronic granulomatous disease with pulmonary mass-like opacities secondary to hypersensitivity pneumonitis: a case report. J Med Case Rep. 2014;8:242.2.CrossRef Katsuya Y, Hojo M, Kawai S, Kawai T, Onodera M, Sugiyama H. Chronic granulomatous disease with pulmonary mass-like opacities secondary to hypersensitivity pneumonitis: a case report. J Med Case Rep. 2014;8:242.2.CrossRef
13.
Zurück zum Zitat Noel N, Mahlaoui N, Blnache S, et al. Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series. J Allergy Clin Immunol. 2013;132(4):997–1000.CrossRefPubMed Noel N, Mahlaoui N, Blnache S, et al. Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series. J Allergy Clin Immunol. 2013;132(4):997–1000.CrossRefPubMed
Metadaten
Titel
Diagnosis of Interstitial Lung Disease Caused by Possible Hypersensitivity Pneumonitis in a Child: Think CGD
verfasst von
Saliha Esenboga
Nagehan Emiralioglu
Deniz Cagdas
Baran Erman
Martin De Boer
Berna Oguz
Nural Kiper
İlhan Tezcan
Publikationsdatum
21.02.2017
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 3/2017
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-017-0376-8

Weitere Artikel der Ausgabe 3/2017

Journal of Clinical Immunology 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.